The Breast Cancer Project

The Breast Cancer Project

One out of eight women will get breast cancer in their lifetime, and every hour nearly five women die from this disease.

Given the critical and all too common occurrence of this form of cancer, the NCC created the Breast Cancer Project to earmark funds specifically for basic research into the causes and potential treatments and cures for this disease.

Our grant to Duke University Medical Center in Durham, NC, funds research into breast cancer genetics and is geared to making existing approaches more effective in the prevention, detection and treatment of breast cancer. This project addresses issues at the cutting edge of cancer immunotherapy.

The Breast Cancer Project

Current Grants and Renewals

National Cancer Center has been proud to award grants to many fine research organizations. We know that a cure lies in research and we are committed to supporting as many research projects as we can.

Xiaowei Wu, Ph.D.

Dana-Farber Cancer Institute, Boston MA

PROJECT: Targeting residual cancer cells upon CDK4/6 inhibition

NEW GRANT

Yi Shi, Ph.D.

Johns Hopkins School of Medicine, Baltimore MD

PROJECT: Intratumoral hypoxia promotes metastatic liver-organotropism in breast cancer

RENEWAL

Youngbin Cho, Ph.D.

University of Pittsburgh, Pittsburgh PA

PROJECT: Myosin II as a target for suppressing tumor-associated macrophage recruitment in triple-negative breast cancer

RENEWAL

Past Beneficiaries

Chiwei Xu, Ph.D.

The Rockefeller Univ, New York, NY

PROJECT: Crosstalk between epithelial stem cells and peripheral nerves in cancer

2021-2022

Ibtehaj Naqvi, M.D., Ph.D.

Duke University, Durham, NC

PROJECT: Mitigating inflammation using nucleic acid scavengers to prevent breast cancer metastasis

2020-2022

David Frankhouser, Ph.D.

Beckman Inst, City of Hope, CA

PROJECT: Detecting Neovascularity in MRI to identify and predict breast cancer

2020-2022

Siang-Boon Koh, Ph.D.

Massachusetts General Hospital Cancer Center

PROJECT: Synergistic targeting of DNA damage response and EMT pathways to reverse RASAL2-driven chemoresistance

2019-2021

Polina Vaitsenfeld, Ph.D.

The Rockefeller University, NY, NY

PROJECT: Enhancing antibody-mediated immunity against tumor-associated carbohydrate antigens
2019-2020

Michael C. Brown Ph.D.

Duke University

PROJECT: Cancer Immunotherapy through intratumoral activation of recall responses
2018-2017

Andrej Gorbatenko

Icahn School of Medicine at Mt Sinai, NY

PROJECT: Novel targeted therapy of inflammatory breast cancer

2016

Laura Saucedo-Cuevas, Ph.D.

Icahn School of Medicine at Mt Sinai, NY

PROJECT: Novel Targeted Therapy of Inflammatory Breast Cancer
2017

Yuntao Mao, Ph.D.

Harvard University

PROJECT: Role of Long Non-coding RNAs in Breast Cancer
2011-2012:  2 year fellowship

0

2023 New and Renewed Research Grants

0

2023 Grants

0

Total Grand Funding To Date